Did not become law. It stopped in the Senate's Appropriations Committee on April 27, 2011. The 2011 session has ended.
2011 Regular Session
Senate Bill 1084
AN ACT CONCERNING OUT-OF-POCKET EXPENSES FOR NONPREFERRED BRAND NAME DRUGS.
What it does
The synopsis the General Assembly published with the bill.
To prohibit insurers from imposing a greater coinsurance, copayment, deductible or other out-of-pocket expense for nonpreferred brand name drugs than for preferred brand name drugs.
Sponsors
Who carried the bill in each chamber, and who signed on. Each name leads to the member's page.
In the Senate
Sponsor
Its course
February 24 to April 27, 2011, on one scale. In the top row each mark is a day something happened; taller marks are busier days.
Each committee stop sits inside its chamber.
Every action10 actions on 7 days
In the SenateFeb 24 to Apr 27 · stopped62 days
Insurance and Real Estate CommitteeFeb 24 to Mar 1519 days
Appropriations CommitteeApr 27 to Apr 27 · stopped0 days
Text
Each version as the General Assembly printed it.
l9n doesn't hold this bill's text yet.
What happened
In l9n's words, one line for each step. Every action as the General Assembly published it is below.
In the Senate Feb 24 – Apr 27
- Feb 24Introduced and sent to Insurance and Real Estate Committee
- Feb 25Heard in Insurance and Real Estate Committee
- Mar 15Insurance and Real Estate Committee recommended it
- Apr 27Sent to Appropriations Committee
All 10 actions, as published
- Feb 24REF. TO JOINT COMM. ONBoth houses
- Feb 25PUBLIC HEARINGBoth houses
- Mar 15Joint FavorableBoth houses
- Mar 16FILED WITH LCOBoth houses
- Mar 21REFERRED TO OLR, OFABoth houses
- Mar 28RPTD. OUT OF LCOBoth houses
- Mar 28FAV. RPT., TAB. FOR CAL., SEN.Senate
- Mar 28SENATE CALENDAR NUMBERSenate
- Mar 28FILE NO.Both houses
- Apr 27REF. BY SEN. TO COMM. ONSenate